We are live on ! Find out more
CVS icon

CVS Health

1,752 hedge funds and large institutions have $73.4B invested in CVS Health in 2025 Q1 according to their latest regulatory filings, with 277 funds opening new positions, 535 increasing their positions, 758 reducing their positions, and 170 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more funds holding in top 10

Funds holding in top 10: 1337 (+24)

63% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 170

55% more capital invested

Capital invested by funds: $47.3B → $73.4B (+$26.1B)

5% more funds holding

Funds holding: 1,6681,752 (+84)

2.63% more ownership

Funds ownership: 83.3%85.93% (+2.6%)

7% more call options, than puts

Call options by funds: $2.18B | Put options by funds: $2.05B

29% less repeat investments, than reductions

Existing positions increased: 535 | Existing positions reduced: 758

Holders
1,752
Holders Change
+84
Holders Change %
+5.04%
% of All Funds
23.49%
Holding in Top 10
37
Holding in Top 10 Change
+24
Holding in Top 10 Change %
+184.62%
% of All Funds
0.5%
New
277
Increased
535
Reduced
758
Closed
170
Calls
$2.18B
Puts
$2.05B
Net Calls
+$135M
Net Calls Change
-$187M
Name Holding Trade Value Shares
Change
Change in
Stake
FFA
776
Farther Finance Advisors
California
$1.11M +$208K +3,481 +27%
PAMG
777
Patton Albertson Miller Group
Tennessee
$1.1M -$131K -2,187 -12%
LFG
778
Lazard Frères Gestion
France
$1.09M -$850K -14,196 -47%
EWA
779
EverSource Wealth Advisors
Alabama
$1.09M -$12.6K -210 -1%
RWPA
780
Richard W. Paul & Associates
Michigan
$1.09M -$26K -435 -3%
SPC
781
Sigma Planning Corp
Michigan
$1.09M -$378K -6,320 -28%
GWM
782
Geneos Wealth Management
Colorado
$1.09M +$618K +10,320 +179%
FFM
783
Forum Financial Management
Illinois
$1.09M -$135K -2,251 -12%
CIAS
784
Capital Investment Advisory Services
North Carolina
$1.09M +$109K +1,815 +13%
TSS
785
Two Sigma Securities
New York
$1.08M +$957K +15,998 New
AFW
786
Avantra Family Wealth
Pennsylvania
$1.08M +$282K +4,704 +42%
KWA
787
Kingswood Wealth Advisors
California
$1.06M -$400K -6,687 -30%
CIA
788
Choate Investment Advisors
Massachusetts
$1.06M +$53.9K +901 +6%
VWM
789
VCI Wealth Management
Missouri
$1.05M -$917K -15,326 -50%
SFG
790
Sterling Financial Group
California
$1.05M +$8.44K +141 +0.9%
KF
791
Krilogy Financial
Missouri
$1.05M +$924K +15,438 New
BTW
792
Boston Trust Walden
Massachusetts
$1.05M -$12K -200 -1%
DJSG
793
D.J. St. Germain
Massachusetts
$1.04M -$14M -233,254 -94%
CCM
794
Chiron Capital Management
Florida
$1.04M -$622K -10,402 -40%
TTIC
795
Tower Trust & Investment Company
Iowa
$1.03M +$923K +15,428 New
CCM
796
Collar Capital Management
Wisconsin
$1.03M +$215K +3,587 +31%
PWM
797
Perigon Wealth Management
California
$1.03M -$289K -4,822 -24%
RRA
798
Round Rock Advisors
Connecticut
$1.03M -$46.1K -770 -5%
LCGC
799
Legacy Capital Group California
California
$1.02M -$7.96K -133 -0.9%
NFG
800
Nations Financial Group
Iowa
$1.02M -$75.9K -1,269 -8%

CVS Hedge Fund Activity: Q1 2025 in Review

1,752 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q1 2025, worth a combined $73.4B — up 55% from $47.3B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 170 closed out — a net gain of 107 holders — while 535 added to existing stakes and 758 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $971M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $309M.

  • 1,752 institutional investors held CVS Health (CVS) as of Q1 2025, up from 1,668 in Q4 2024.
  • Funds reported $73.4B of CVS Health stock for Q1 2025, up 55% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q1 2025 and 170 closed out, a net change of +107 holders.
  • The largest CVS Health buyer in Q1 2025 was Capital Research Global Investors, an estimated $971M added.
  • The largest CVS Health seller in Q1 2025 was Hotchkis & Wiley Capital Management, an estimated $309M sold.

Based on aggregated 13F filings for Q1 2025.